Literature DB >> 2324518

Epidermal and dermal effects of epidermal growth factor during wound repair.

L B Nanney1.   

Abstract

Epidermal growth factor (EGF), a well-characterized peptide that stimulates in vitro cell proliferation, has now been shown to enhance in vivo resurfacing of porcine wounds. Topical formulations containing either recombinant EGF or placebo were applied daily to partial-thickness wounds along the dorsal surface of pigs. Following full-thickness removal of these wounds, tissues were sectioned and stained, and histologic sections were subjected to computerized morphometric analysis. A significant acceleration of epithelialization across the wound surface was noted following daily EGF treatments. EGF delivered in a variety of topical formulations also produced a marked increase in the cellularity and thickness in the neodermis. A dose-responsive increase in the thickness of the granulation tissue was also observed. In conclusion, topical application of EGF stimulates epithelialization of partial-thickness wounds and produces a positive impact on the underlying dermis during the early phases of wound repair.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2324518     DOI: 10.1111/1523-1747.ep12876204

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  33 in total

1.  Delayed wound healing in CXCR2 knockout mice.

Authors:  R M Devalaraja; L B Nanney; J Du; Q Qian; Y Yu; M N Devalaraja; A Richmond
Journal:  J Invest Dermatol       Date:  2000-08       Impact factor: 8.551

2.  Heparin-binding ligands mediate autocrine epidermal growth factor receptor activation In skin organ culture.

Authors:  S Stoll; W Garner; J Elder
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 3.  [Fetal wound healing: current status and new perspectives].

Authors:  E A Huhn; C Jannowitz; H Boos; M A Papadopulos; H F Zeilhofer; J Henke; D Müller; L Kovacs; E Biemer; N A Papadopulos
Journal:  Chirurg       Date:  2004-05       Impact factor: 0.955

Review 4.  Platelet-rich plasma and platelet gel: a review.

Authors:  Peter A M Everts; Johannes T A Knape; Gernot Weibrich; Jacques P A M Schönberger; Johannes Hoffmann; Eddy P Overdevest; Henk A M Box; André van Zundert
Journal:  J Extra Corpor Technol       Date:  2006-06

5.  Comparison of skin effects of immediate treatment modalities in experimentally induced hydrofluoric acid skin burns.

Authors:  Meltem K Songur; Ovunc Akdemir; William C Lineaweaver; Turker Cavusoglu; Murat Ozsarac; Huseyin Aktug; Ecmel Songur; Yigit O Tiftikcioglu
Journal:  Int Wound J       Date:  2014-01-29       Impact factor: 3.315

6.  Altered CXCR2 signaling in beta-arrestin-2-deficient mouse models.

Authors:  Yingjun Su; Sandeep K Raghuwanshi; Yingchun Yu; Lillian B Nanney; Ricardo M Richardson; Ann Richmond
Journal:  J Immunol       Date:  2005-10-15       Impact factor: 5.422

7.  Transforming growth factor-alpha (TGF-alpha) in a semisolid dosage form: preservative and vehicle selection.

Authors:  E L Tan; H S Shah; K J Leister; L M Kozick; P Pasciak; R K Vanderlaan; C D Yu; B Patel
Journal:  Pharm Res       Date:  1993-08       Impact factor: 4.200

8.  The combined effect of recombinant human epidermal growth factor and erythropoietin on full-thickness wound healing in diabetic rat model.

Authors:  Joon Pio Hong; Sung Woo Park
Journal:  Int Wound J       Date:  2012-10-19       Impact factor: 3.315

9.  The use of recombinant human epidermal growth factor to promote healing for chronic radiation ulcer.

Authors:  Sang-wook Lee; Sue Young Moon; Yeun Hwa Kim; Joon Pio Hong
Journal:  Int Wound J       Date:  2007-09       Impact factor: 3.315

10.  Epidermal growth factor receptors in idiopathic and virally induced skin diseases.

Authors:  L B Nanney; D L Ellis; J Levine; L E King
Journal:  Am J Pathol       Date:  1992-04       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.